![Kristen Slaoui](data:image/svg+xml,<svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" fill="%231b1b1b" class="bi bi-person-fill" viewBox="0 0 16 16"><path d="M3 14s-1 0-1-1 1-4 6-4 6 3 6 4-1 1-1 1zm5-6a3 3 0 1 0 0-6 3 3 0 0 0 0 6"/></svg>)
Kristen Slaoui
Direktor/Vorstandsmitglied bei
Kinaset Therapeutics, Inc.
Vermögen: - $ am 30.06.2026
Profil
Kristen Belmonte Slaoui is currently Director at Kinaset Therapeutics, Inc. and Chief Corporate Development Officer at Galderma SA (Switzerland).
Former roles include Director at Villaris Therapeutics, Inc. from 2019 to 2022, Independent Director at Achieve Life Sciences, Inc. from 2025 to 2026, Vice President at Tesaro, Inc., Vice President & Head-Business Development at GSK Plc from 2015 to 2020, and Vice President-Business Development & Licensing at Stiefel Laboratories, Inc. from 2012 to 2020.
Education includes undergraduate studies at Gettysburg College and a doctorate from Johns Hopkins Bloomberg School of Public Health.
Bekannte Unternehmensbeteiligungen
| Unternehmen | Datum | Anzahl der Aktien | Bewertung | Datum der Bewertung |
|---|---|---|---|---|
| 20.04.2026 | 0 ( -.--% ) | - $ | 30.06.2026 |
Aktive Positionen von Kristen Slaoui
| Unternehmen | Position | Beginn |
|---|---|---|
Kinaset Therapeutics, Inc.
 Kinaset Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Develops inhaled therapeutics for respiratory diseases | Direktor/Vorstandsmitglied | - |
Galderma SA (Switzerland)
 Galderma SA (Switzerland) Pharmaceuticals: MajorHealth Technology Manufactures and distributes dermatology products | Corporate Officer/Principal | - |
Ehemalige bekannte Positionen von Kristen Slaoui
| Unternehmen | Position | Ende |
|---|---|---|
| ACHIEVE LIFE SCIENCES, INC. | Direktor/Vorstandsmitglied | 02.07.2026 |
Villaris Therapeutics, Inc.
 Villaris Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Operates as an asset-centric biopharmaceutical company | Direktor/Vorstandsmitglied | 01.11.2022 |
Stiefel Laboratories, Inc.
 Stiefel Laboratories, Inc. Pharmaceuticals: MajorHealth Technology Manufactures pharmaceutical products | Corporate Officer/Principal | 02.08.2020 |
| GSK PLC | Corporate Officer/Principal | 01.08.2020 |
| TESARO INC | Corporate Officer/Principal | - |
Ausbildung von Kristen Slaoui
Erfahrungen
Besetzte Positionen
Aktive
Inaktive
Börsennotierte Unternehmen
Private Unternehmen
Beziehungen
60
Beziehungen ersten Grades
9
Unternehmen ersten Grades
Herr
Frau
Aufsichtsräte
Führungskräfte
Unternehmensverbindungen
| Private Unternehmen | 9 |
|---|---|
Tesaro, Inc.
 Tesaro, Inc. Pharmaceuticals: MajorHealth Technology Operates as a biopharmaceutical company that develops drugs for cancer patients | Health Technology |
GSK Plc
 GSK Plc Pharmaceuticals: MajorHealth Technology Develops, manufactures and distributes vaccines and other pharmaceutical products | Health Technology |
Gettysburg College
 Gettysburg College Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Stiefel Laboratories, Inc.
Stiefel Laboratories, Inc. Pharmaceuticals: MajorHealth Technology Manufactures pharmaceutical products | Health Technology |
Johns Hopkins Bloomberg School of Public Health
 Johns Hopkins Bloomberg School of Public Health Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Galderma SA (Switzerland)
Galderma SA (Switzerland) Pharmaceuticals: MajorHealth Technology Manufactures and distributes dermatology products | Health Technology |
Achieve Life Sciences, Inc.
 Achieve Life Sciences, Inc. Pharmaceuticals: MajorHealth Technology Develops and commercializes cytisinicline for smoking cessation and nicotine addiction | Health Technology |
Kinaset Therapeutics, Inc.
Kinaset Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Develops inhaled therapeutics for respiratory diseases | Health Technology |
Villaris Therapeutics, Inc.
Villaris Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Operates as an asset-centric biopharmaceutical company | Health Technology |
Wählen Sie MarketScreener 
